As a final part of the project, ASKLEPIOS will bring together the knowledge acquired in the different workpackages and use the mouse model to test the efficiency of the identified molecules to improve clinical course of rabies encephalitis. Molecules will be tested either alone or in combination with or without BBB openers.
In vivo testing of (combination of) therapeutic molecules
World Health Organisation- WHO and UNICEF issue new guidance to promote breastfeeding in health facilities globallyWHO and UNICEF today issued new ten-step guidance to increase support for breastfeeding in health facilities that provide maternity and newborn services. Breastfeeding all babies for the first 2 years would save the lives of more than 820 000 children under age 5 annually. The Ten Steps to Successful Breastfeeding underpin the Baby-friendly Hospital Initiative, […]
- WHO concerned about suspected chemical attacks in SyriaWHO is deeply alarmed by reports of the suspected use of toxic chemicals in Douma city, East Ghouta. According to reports from Health Cluster partners, during the shelling of Douma on Saturday, an estimated 500 patients presented to health facilities exhibiting signs and symptoms consistent with exposure to toxic chemicals. In particular, there were signs […]
- Nearly one billion people in Africa to be protected against yellow fever by 2026Nearly one billion people will be vaccinated against yellow fever in 27 high-risk African countries by 2026 with support from WHO, Gavi – the Vaccine Alliance, UNICEF and more than 50 health partners. The commitment is part of the Eliminate Yellow fever Epidemics (EYE) in Africa strategy, which was launched by Dr Tedros Adhanom Ghebreyesus, […]
- WHO and UNICEF issue new guidance to promote breastfeeding in health facilities globally